Medicine for treating asthma

Abstract

The invention relates to a medicine for treating asthma; the medicine is prepared from the following materials in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of herba aristolochiae, 10-20 parts of radices sileris, 15-30 parts of ephedra, 20-30 parts of fructus terminaliae billericae, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of lalang grass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of camuning, 10-20 parts of rainbow conk, 15-20 parts of herba inulae, 15-30 parts of herb of glabrous sarcandra, 10-20 parts of clinopodium polycephalum, 10-25 parts of cortex periplocae, 5-15 parts of aleppo avens, 1-20 parts of herba eupatorii, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of the root bark of white mulberry, 20-30 parts of lindley eupatorium, 1-20 parts of teasel root and 10-25 parts of lily. The components of the medicine provided by the invention for treating asthma are all natural materials, and therefore the medicine is relatively excellent in safety, is exact in curative effect and is suitable for large-scale clinical promotion.

Description

Technical field [0001] The present invention relates to the field of medicine, in particular to a medicament for treating asthma. Background technique [0002] Asthma is a chronic airway inflammation involving a variety of cells, especially mast cells, eosinophils, and T lymphocytes. In susceptible people, this inflammation can cause recurrent symptoms such as wheezing, shortness of breath, chest tightness, and coughing. Occurs mostly at night or in the early morning; this symptom is often accompanied by extensive and variable expiratory flow limitation, but it can be partially relieved naturally or after treatment; this symptom is also accompanied by airway responsiveness to multiple stimulating factors Increase. In order to solve these pains, people have conducted a lot of research, but the treatment effect is not particularly ideal. Summary of the invention [0003] The object of the present invention is to provide an agent for treating asthma. [0004] In order to achieve the...

AI Technical Summary

Problems solved by technology

In order to solve these pains, people have conducted a lot of research, but the treatment effect is not particularly satisfactory